| Literature DB >> 21288350 |
Heidi J Silver1, Mary S Dietrich, Kevin D Niswender.
Abstract
BACKGROUND: Reducing dietary energy density has proven to be an effective strategy to reduce energy intakes and promote weight control. This effect appears most robust when a low energy dense preload is consumed before meals. Yet, much discussion continues regarding the optimal form of a preload. The purpose of the present study was to compare effects of a solid (grapefruit), liquid (grapefruit juice) and water preload consumed prior to breakfast, lunch and dinner in the context of caloric restriction.Entities:
Year: 2011 PMID: 21288350 PMCID: PMC3039556 DOI: 10.1186/1743-7075-8-8
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Figure 1Flow diagram of study subjects from eligibility criteria screening to study completion. GF = grapefruit; GFJ = grapefruit juice.
Preload Properties *
| Weight | Energy | Energy Density | Water | Vitamin C | Fiber | Naringin** | |
|---|---|---|---|---|---|---|---|
| (g) | (kcal) | (kcal/g) | (g) | (mg) | (g) | (mg) | |
| Grapefruit | 128 | 42 | 0.331 | 115.8 | 42.3 | 1.13 | 27.1 |
| Grapefruit Juice | 127 | 46 | 0.370 | 115.0 | 48.3 | 0.13 | 39.6 |
| Water | 127 | 0 | 0 | 127.0 | 0 | 0 | 0 |
*The amounts of each variable are based on averaging several pieces of fruit and juice using values obtained from NDS-R, Bowes & Church's [34], and data provided by the State of Florida Department of Citrus.
**Naringin content was chosen to represent bioflavonoid content as it comprises the majority of total flavanones in GF and GFJ, and has been associated with changes in cardiometabolic risk factors. The Davis spectrophotometric method [66] was used to determine flavanones contents.
Baseline Descriptive Characteristics of Subjects Randomized to Preload Group (n = 85)*
| Characteristic | Grapefruit Group | Grapefruit Juice Group | Water Group |
|---|---|---|---|
| (n = 29) | (n = 28) | (n = 28) | |
| Completed Study (#, %) | 23 (79.3%) | 22 (78.6%) | 23 (82.1%) |
| Gender | |||
| Male | 11 (37.9%) | 3 (10.7%) | 7 (25%) |
| Female | 18 (62.1%) | 25 (89.3%) | 21 (75%) |
| Race | |||
| Caucasian | 13 (44.8%) | 19 (67.9%) | 19 (67.9%) |
| African American | 16 (55.2%) | 9 (32.1%) | 9 (32.1%) |
| Education | |||
| High School Degree | 3 (10.3%) | 3 (10.7%) | 3 (10.7%) |
| Undergraduate Degree | 15 (51.7%) | 17 (60.7%) | 21 (75.0%) |
| Graduate Degree | 11 (37.9%) | 8 (28.6%) | 4 (14.3%) |
| Past Smokerc | 2 (6.9%) | 5 (17.9%) | 3 (10.7%) |
| Age (years ± SD)a | 37.6 ± 7.4 | 39.8 ± 8.4 | 38.7 ± 8.8 |
| Height (cm ± SD) | 165.9 ± 8.4 | 165.1 ± 6.4 | 166.9 ± 8.9 |
| Weight (kg ± SD) | 99.8 ± 13.8 | 95.9 ± 11.5 | 99.5 ± 13.5 |
| Body Mass Index (mean ± SD)b | 36.3 ± 3.1 | 35.2 ± 3.1 | 35.7 ± 3.5 |
| Assessment of Eating Disorder | |||
| EAT-26d | 10.6 ± 6.4 | 10.4 ± 5.9 | 9.1 ± 5.9 |
| Dietary Restraint Scoree | 10.5 ± 4.4 | 10.9 ± 3.5 | 10.7 ± 4.0 |
| Disinhibition Scoree | 7.5 ± 2.7 | 8.2 ± 3.4 | 8.6 ± 3.0 |
| Hunger Tendency Scoree | 5.3 ± 2.6 | 6.3 ± 3.2 | 6.1 ± 3.3 |
| Depression History | 1 (3.4%) | 3 (10.7%) | 2 (7.1%) |
| Metabolic Syndromef | 11 (37.9%) | 6 (21.4%) | 6 (21.4%) |
a. Age 21-50 years required at study entry.
b. BMI 30-39.9 required to meet study eligibility.
c. Current (within past year) non-smoker required to meet study eligibility.
d. EAT-26 measures general eating disorder pathology; score ≥ 20 was criteria for study exclusion.
e. Three Factor Eating Questionnaire, dietary restraint score ≥ 14 was criteria for study exclusion.
f. Meeting ≥ 3 of 5 NCEP-ATPIII criteria.
* Demographic characteristics were not significantly different at baseline among randomly assigned preload groups based on Chi-square test of independence for categorical variables and one-way ANOVA for continuous variables.
Change in Outcome Variables from Baseline to Study Completion by Preload Group
| GF Preload | GFJ Preload | Water Preload | ||
|---|---|---|---|---|
| (mean ± SD) | (mean ± SD) | (mean ± SD) | ||
| RQ (VCO2/VO2) | 0.0 ± 0.1 | 0.0 ± 0.1 | 0.0 ± 0.1 | 0.618 |
| REE (kcal) | 4.5 ± 27.9 | 42.1 ± 18.4 | - 37.1 ± 22.6 | 0.151 |
| REE Adjusted (kcal/kg/lbm) | 1.6 ± 4.6 | 1.7 ± 5.1 | 0.9 ± 5.2 | 0.078 |
| Body Mass Index (kg/m2) | - 1.6 ± 1.6 | - 1.9 ± 1.4 | - 2.1 ± 1.1 | 0.523 |
| Waist Circumference (cm) | - 4.0 ± 4.1 | - 5.5 ± 5.7 | - 5.4 ± 4.8 | 0.189 |
| Fat Tissue Mass (kg) | - 2.6 ± 2.1 | - 2.9 ± 2.9 | - 2.5 ± 2.1 | 0.499 |
| Total Body Fat (%) | - 1.1 ± 1.8 | - 1.1 ± 1.9 | - 1.2 ± 2.6 | 0.489 |
| Trunk Fat (%) | - 1.4 ± 2.9 | - 1.7 ± 2.6 | - 1.2 ± 2.6 | 0.154 |
| Android Fat (%) | - 1.9 ± 2.4 | - 1.2 ± 2.7 | - 1.5 ± 3.3 | 0.239 |
| Gynoid Fat (%) | - 1.5 ± 2.4 | - 0.5 ± 2.9 | - 0.7 ± 4.5 | 0.114 |
| Lean Tissue Mass (kg) | - 0.9 ± 2.1 | - 1.9 ± 1.9 | 0.3 ± 2.4 | 0.127 |
| Lean Tissue Mass (%) | 1.1 ± 2.4 | 0.8 ± 2.0. | 1.8 ± 2.6 | 0.230 |
| BMC (kg) | 0.2 ± 0.2 | 0.0 ± 0.1 | 0.1 ± 0.2 | 0.587 |
| Fasting Glucose (mmol/L) | 0.1 ± 0.3 | 0.1 ± .0.4 | 0.0 ± 0.4 | 0.969 |
| Fasting Insulin (uU/mL) | - 0.5 ± 4.7 | - 0.3 ± 3.7 | - 0.8 ± 7.4 | 0.691 |
| HOMAIR Score | - 0.2 ± 1. | - 0.1 ± 0.8 | - 0.6 ± 1.6 | 0.095 |
| Systolic Blood Pressure (mmHg) | - 3.1 ± 7.8 | -3.1 ± 7.4 | - 1.5 ± 6.3 | 0.922 |
| Diastolic Blood Pressure (mmHg) | - 0.3 ± 8.1 | - 3.8 ± 9.1 | 0.1 ± 8.1 | 0.565 |
| Triglycerides (mg/dl) | - 6.7 ± 40.6 | - 9.4 ± 31.9 | - 4.3 ± 26.2 | 0.166 |
| Total cholesterol (mg/dl) | 3.0 ± 21.3 | - 3.2 ± 14.9 | 2.5 ± 11.1 | 0.419 |
| LDL cholesterol (mg/dl) | 1.8 ± 3.2 | 5.3 ± 7.9 | 3.5 ± 7.7 | 0.498 |
| HDL cholesterol (mg/dl) | 3.0 ± 5.2 | 4.9 ± 7.5** | -2.0 ± 7.2 | 0.020 |
| HDL to total cholesterol ratio | - 0.2 ± 0.4 | - 0.4 ± 0.7** | 0.2 ± 0.6 | 0.025 |
*P <. 0.05 indicating statistically significant difference by ANCOVA, with baseline value included as covariate. For outcomes showing significant differences by ANCOVA, simple contrasts were conducted within ANCOVA to determine which preloads were significantly different.
** Significantly different from water preload, Ps = 0.017.
Figure 2Total Amount of Food Consumed at Baseline (Week 0), End of Caloric Restriction Phase (Week 2) and End of Caloric Restriction + Preload Phase (Week 14)*. * Total Amount of Food = Average daily quantity of food consumed, includes dietary preloads (~127 g) during the caloric restriction + preload phase (week 14). Change in amount consumed not significantly different among preload groups based on ANCOVA.
Figure 3Dietary Energy Density at Baseline, End of Caloric Restriction Phase (Week 2) and End of Caloric Restriction + Preload Phase (Week 14)*. Dietary Energy Density = Average daily dietary energy density; includes GF, GFJ or water preload during the caloric restriction + preload phase (week 14). * Significantly different from baseline value based on ANCOVA with contrasts, P < 0.01.
Figure 4Total Energy Intakes at Baseline, End of Caloric Restriction Phase (Week 2) and End of Caloric Restriction + Preload Phase (Week 14)*. Total Energy Intakes = Average total daily energy intakes consumed; includes energy from dietary preloads (~46 kcal) during caloric restriction + preload phase (week 14). * Significantly different from baseline value based on ANCOVA with contrasts, P < 0.01.